# Solasta Ventures

Solasta Ventures is a Venture Capital based in Boston, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Boston, United States
- **Region:** North America
- **Address:** Prudential Tower, 800 Boylston Street, Suite 2510, Boston, MA 02199, United States
- **Founded:** 2013
- **Assets under management:** Undisclosed
- **Website:** www.solasta-ventures.com
- **LinkedIn:** https://www.linkedin.com/company/solasta-ventures

## Regulatory record

- **CRD number:** 305520
- **SEC file number:** 802-117496
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/305520

## About

Solasta Ventures, Inc. (formerly known in the U.S. as Aju IB Investment) is a wholly-owned subsidiary of Aju IB Investment, a leading South Korean venture capital firm. The firm is committed to investing in innovative companies that advance the standard of care for diseases with unmet medical needs. Its team leverages deep scientific expertise and an extensive network to identify promising therapeutics and discovery platforms that have the potential to transform patients’ lives worldwide.

## Sectors

- Digital Health
- Healthcare Services

## Offices

- San Francisco, CA, United States

## People

- Derek Yoon — President & CEO
- Michael Jeon — Managing Partner
- William C. Hahn, M.D., Ph.D. — Scientific Advisory Board
- Byoung Chul Cho, M.D., Ph.D. — Scientific Advisory Board

## Questions

### How is Solasta Ventures related to Aju IB Investment?

Solasta Ventures is the wholly-owned US subsidiary of Aju IB Investment, a leading South Korean venture capital firm. It previously operated under the Aju IB Investment name in the United States before rebranding to Solasta Ventures. The parent relationship provides Solasta with a direct channel to Korean institutional limited partners.

### What does Solasta Ventures invest in?

The firm invests in early-stage therapeutics and drug-discovery platforms targeting diseases with significant unmet medical need. It focuses on US-based life-science companies, using its scientific advisory board to evaluate the underlying biology and clinical potential of each opportunity.

### Who sits on Solasta's scientific advisory board?

Two named members serve: William C. Hahn, M.D., Ph.D., of the Dana-Farber Cancer Institute, and Byoung Chul Cho, M.D., Ph.D. They provide technical diligence on therapeutic and platform investments, drawing on their own active research programs.

### Does Solasta Ventures invest outside the United States?

The firm's office footprint — Boston and San Francisco — and its stated investment mandate point to a US-only focus. No non-US portfolio companies are publicly disclosed, and the parent entity, Aju IB Investment, covers the Korean market separately.

## Related profiles

- [Solas BioVentures](https://altss.com/profile/solas-bioventures)
- [Solborn Venture Investment](https://altss.com/profile/solborn-venture-investment)

---

Last updated: 2026-08-11T15:08:11.274Z

Canonical page: https://altss.com/profile/solasta-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology